PIM
Platinum Investment Management Portfolio holdings
AUM
$1.5B
This Quarter Return
-4.65%
1 Year Return
+16.62%
3 Year Return
+100.57%
5 Year Return
+187.54%
10 Year Return
+422.09%
AUM
$1.73B
AUM Growth
+$1.73B
(+1.4%)
Cap. Flow
+$120M
Cap. Flow
% of AUM
6.96%
Top 10 Holdings %
Top 10 Hldgs %
64.87%
Holding
130
New
15
Increased
46
Reduced
33
Closed
15
Top Buys
| 1 |
UBS Group
UBS
|
$132M |
| 2 |
Merck
MRK
|
$92.9M |
| 3 |
AbbVie
ABBV
|
$87.7M |
| 4 |
Lam Research
LRCX
|
$82M |
| 5 |
Valaris
VAL
|
$56.5M |
Top Sells
| 1 |
Nice
NICE
|
$68.8M |
| 2 |
Lamb Weston
LW
|
$67M |
| 3 |
Intercontinental Exchange
ICE
|
$64.6M |
| 4 |
Pinduoduo
PDD
|
$46.7M |
| 5 |
Baxter International
BAX
|
$44M |
Sector Composition
| 1 | Financials | 22.28% |
| 2 | Technology | 16.49% |
| 3 | Energy | 15.11% |
| 4 | Healthcare | 14.95% |
| 5 | Industrials | 11.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Zoetis
ZTS
$69.3B
| $6.59M | 0.38% | 40,000 | – | – |
|
27
Johnson & Johnson
JNJ
$427B
| $5.96M | 0.35% | 35,942 | – | – |
|
|
XYZ
28
Block, Inc.
XYZ
$48.5B
| $5.59M | 0.32% | +102,959 | New | +$5.59M |
|
29
Birkenstock
BIRK
$9.59B
| $5.5M | 0.32% | 120,000 +30,000 | +33% | +$1.38M |
|
30
Amer Sports
AS
$21.8B
| $5.35M | 0.31% | 200,000 -50,000 | -20% | -$1.34M |
|
31
CoStar Group
CSGP
$37.9B
| $5.15M | 0.3% | 65,000 -5,000 | -7% | -$396K |
|
32
Roivant Sciences
ROIV
$8.15B
| $5M | 0.29% | 495,797 -32,234 | -6% | -$325K |
|
33
Alibaba
BABA
$322B
| $4.27M | 0.25% | 32,319 +3,474 | +12% | +$459K |
|
|
CNTA
34
Centessa Pharmaceuticals
CNTA
$2.25B
| $3.85M | 0.22% | 267,887 -102,391 | -28% | -$1.47M |
|
35
Veeva Systems
VEEV
$44B
| $3.82M | 0.22% | 16,508 -611 | -4% | -$142K |
|
36
Apogee Therapeutics
APGE
$2.17B
| $3.57M | 0.21% | 95,646 | – | – |
|
37
Microsoft
MSFT
$3.77T
| $3.51M | 0.2% | 9,340 +351 | +4% | +$132K |
|
38
Netflix
NFLX
$513B
| $3.37M | 0.2% | 3,618 | – | – |
|
39
Vera Therapeutics
VERA
$1.38B
| $3.35M | 0.19% | 139,318 +19,654 | +16% | +$472K |
|
40
Zymeworks
ZYME
$1.12B
| $3.32M | 0.19% | 278,658 -27,802 | -9% | -$331K |
|
41
ADC Therapeutics
ADCT
$345M
| $2.87M | 0.17% | 2,038,087 +425,531 | +26% | +$600K |
|
42
Mastercard
MA
$538B
| $2.87M | 0.17% | 5,234 -191 | -4% | -$105K |
|
43
Merus
MRUS
$4.98B
| $2.73M | 0.16% | 64,841 -4,244 | -6% | -$179K |
|
44
Immunovant
IMVT
$2.56B
| $2.68M | 0.16% | 156,989 -45,334 | -22% | -$775K |
|
45
NVIDIA
NVDA
$4.24T
| $2.65M | 0.15% | 24,479 +22,897 | +1,447% | +$2.48M |
|
46
Wave Life Sciences
WVE
$1.53B
| $2.52M | 0.15% | 311,992 | – | – |
|
47
e.l.f. Beauty
ELF
$7.09B
| $2.51M | 0.15% | 40,000 +2,700 | +7% | +$170K |
|
48
IDEAYA Biosciences
IDYA
$2.15B
| $2.5M | 0.14% | 152,713 | – | – |
|
|
BCYC
49
Bicycle Therapeutics
BCYC
$511M
| $2.44M | 0.14% | 287,599 -21,460 | -7% | -$182K |
|
50
BridgeBio Pharma
BBIO
$9.89B
| $2.43M | 0.14% | +70,350 | New | +$2.43M |
|